# Actuate Therapeutics, Inc.: Form 8-K, filed Sep 10, 2025

- Company: [Actuate Therapeutics, Inc.](/companies/actu.md) (CIK 1652935)
- Form: 8-K
- Filed: 2025-09-10
- Accepted by EDGAR: Sep 10, 2025, 17:11 ET
- Period: 2025-09-10
- Accession: 0001683168-25-006831
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/actuate_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/actuate_8k.htm

Filed Sep 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-006831. Last ingested by Listed: Nov 2, 2026, 18:06 ET. No prices; not investment advice.